TY - JOUR
AU - REMAP-CAP Investigators
PY - 2023
DA - October
TI - Simvastatin in Critically Ill Patients with Covid-19
JO - New England Journal of Medicine
EP - 2354
VL - 389
IS - 25
DO - https://doi.org/10.1056/NEJMoa2309995
AB - BACKGROUND: The efficacy of simvastatin in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear.
PB - Massachusetts Medical Society
UR - https://www.research.ed.ac.uk/en/publications/d8bc560c-67bc-42e2-95ca-1cf0774c0ae3
KW - Coronavirus (COVID-19)
ER